IXO Private Equity is a venture capital fund based in Toulouse, focusing on Series A and Series C investments in sectors such as biotech, health tech, fintech, AI, and productivity tools. They typically invest between $2 million and $15 million. Notable investments include Antabio and Indy. Managing over €610 million in assets, the fund primarily targets businesses in the South of France and the Rhône-Alpes region. The team comprises 19 professionals, including 14 experienced investors.
